Johnson & Johnson (JNJ)
160.65
+1.01
(+0.63%)
USD |
NYSE |
Jul 26, 16:00
160.50
-0.15
(-0.09%)
After-Hours: 20:00
Johnson & Johnson Market Cap: 386.63B for July 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| July 25, 2024 | 384.20B |
| July 24, 2024 | 376.12B |
| July 23, 2024 | 366.66B |
| July 22, 2024 | 371.21B |
| July 19, 2024 | 372.29B |
| July 18, 2024 | 374.05B |
| July 17, 2024 | 376.84B |
| July 16, 2024 | 363.43B |
| July 15, 2024 | 359.17B |
| July 12, 2024 | 360.71B |
| July 11, 2024 | 360.28B |
| July 10, 2024 | 359.63B |
| July 09, 2024 | 353.90B |
| July 08, 2024 | 350.12B |
| July 05, 2024 | 352.53B |
| July 03, 2024 | 350.63B |
| July 02, 2024 | 351.45B |
| July 01, 2024 | 352.43B |
| June 28, 2024 | 351.76B |
| June 27, 2024 | 350.89B |
| June 26, 2024 | 353.35B |
| June 25, 2024 | 354.24B |
| June 24, 2024 | 358.88B |
| June 21, 2024 | 357.99B |
| June 20, 2024 | 355.66B |
| Date | Value |
|---|---|
| June 18, 2024 | 350.53B |
| June 17, 2024 | 351.25B |
| June 14, 2024 | 350.27B |
| June 13, 2024 | 350.05B |
| June 12, 2024 | 349.96B |
| June 11, 2024 | 353.20B |
| June 10, 2024 | 354.09B |
| June 07, 2024 | 353.97B |
| June 06, 2024 | 352.39B |
| June 05, 2024 | 351.30B |
| June 04, 2024 | 355.71B |
| June 03, 2024 | 355.56B |
| May 31, 2024 | 352.99B |
| May 30, 2024 | 349.64B |
| May 29, 2024 | 347.62B |
| May 28, 2024 | 347.48B |
| May 24, 2024 | 353.71B |
| May 23, 2024 | 360.28B |
| May 22, 2024 | 369.43B |
| May 21, 2024 | 363.99B |
| May 20, 2024 | 364.06B |
| May 17, 2024 | 372.17B |
| May 16, 2024 | 371.30B |
| May 15, 2024 | 367.43B |
| May 14, 2024 | 364.32B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
293.00B
Minimum
Mar 23 2020
489.47B
Maximum
Apr 25 2022
408.12B
Average
409.12B
Median
Market Cap Benchmarks
| Eli Lilly and Co | 724.93B |
| Merck & Co Inc | 317.39B |
| Pfizer Inc | 174.39B |
| AbbVie Inc | 326.95B |
| Bristol-Myers Squibb Co | 102.17B |
Market Cap Related Metrics
| PE Ratio | 10.60 |
| PS Ratio | 4.562 |
| PEG Ratio | 0.0513 |
| Price to Book Value | 5.522 |
| Price | 160.65 |
| Earnings Yield | 9.43% |
| PEGY Ratio | 0.0506 |
| Operating PE Ratio | 16.78 |
| Normalized PE Ratio | 19.50 |